A STEP TOWARDS BETTER CONTROL

 

COMPOSITION

Linagliptin 5mg + Dapagliflozin 10mg

INDICATION

Type 2 Diabetes

Linovio-D

  • Increases insulin secretion and decrease glucagon secretion, helps to lower blood sugar levels. Biopharm.
    Drug Dispos 2017-38,273-270
  • Selectively inhibits SGLT-2, promotes the excretion of excess glucose through the urine, thus lowers blood sugar levels with beneficial effects on the cardiovascular system. Cures 2017 Dot 5,9/10×1751, Crauletion 2016, 130 762-772
  • The combined use of dapagliflozin and linagliptin is safe and tolerable.